Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system

Nature Medicine

Volumn 18, Issue 3, 2012, Pages 344-346

  Ciampricotti, Metamia ^a   Hau, Cheei Sing ^a   Doornebal, Chris W ^a   Jonkers, Jos ^a   De Visser, Karin E ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CD4 ANTIGEN; CD8 ANTIGEN; CISPLATIN; DOXORUBICIN; OXALIPLATIN; TRANSCRIPTION FACTOR FOXP3;

ADAPTIVE IMMUNITY; APOPTOSIS; BREAST TUMOR; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DRUG EFFICACY; IMMUNOGENICITY; LETTER; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; TREATMENT RESPONSE; TUMOR MICROENVIRONMENT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CALRETICULIN; CARRIER PROTEINS; COLONIC NEOPLASMS; DENDRITIC CELLS; HUMANS; INTERLEUKIN-1BETA; NEOPLASMS; TOLL-LIKE RECEPTOR 4;

EID: 84857954861     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2652     Document Type: Letter

References (10)

1. Apetoh, L. et al. Nat. Med. 13, 1050-1059 (2007).
2. Obeid, M. et al. Nat. Med. 13, 54-61 (2007).
3. Ghiringhelli, F. et al. Nat. Med. 15, 1170-1178 (2009).
4. Schreiber, K., Rowley, D.A., Riethmuller, G. & Schreiber, H. Hematol. Oncol. Clin. North Am. 20, 567-584 (2006).
5. Mattarollo, S.R. et al. Cancer Res. 71, 4809-4820 (2011).
6. Olive, K.P. et al. Science 324, 1457-1461 (2009).
7. Willimsky, G. et al. J. Exp. Med. 205, 1687-1700 (2008).
8. DeNardo, D.G. et al. Cancer Discov. 1, 54-67 (2011).
9. Ramakrishnan, R. et al. J. Clin. Invest. 120, 1111-1124 (2010).
10. Robert, C. et al. N. Engl. J. Med. 364, 2517-2526 (2011).